NCT05295407 Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
| NCT ID | NCT05295407 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Endeavor Health |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-12-13 |
| Primary Completion | 2026-12-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-12-13 with a primary completion date of 2026-12-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment
Eligibility Criteria
Inclusion Criteria: * Consecutive patients undergoing prostate biopsy for detection of prostate cancer * Aged 40 to 69 years * Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos) * PSA between 2.5-10 ng/mL Exclusion Criteria: * Previous diagnosis of prostate cancer. * Ethnicity outside the inclusion criterion (including mixed ethnicity). * Any prior PSA test result outside the range of inclusion criterion.
Contact & Investigator
Jianfeng Xu, MD, Dr.PH
PRINCIPAL INVESTIGATOR
Endeavor Health
Frequently Asked Questions
Who can join the NCT05295407 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 69 Years, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05295407 currently recruiting?
Yes, NCT05295407 is actively recruiting participants. Contact the research team at aashworth@northshore.org for enrollment information.
Where is the NCT05295407 trial being conducted?
This trial is being conducted at Evanston, United States.
Who is sponsoring the NCT05295407 clinical trial?
NCT05295407 is sponsored by Endeavor Health. The principal investigator is Jianfeng Xu, MD, Dr.PH at Endeavor Health. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.